Anita D'Souza Selected Research

Immunoglobulin Subunits

12/2017

Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anita D'Souza Research Topics

Disease

60	Multiple Myeloma 03/2024 - 09/2013
22	Neoplasms (Cancer) 03/2024 - 07/2017
20	Amyloidosis 01/2023 - 11/2012
16	Immunoglobulin Light-chain Amyloidosis 11/2023 - 12/2014
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 10/2016
6	Infections 03/2024 - 11/2020
6	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 01/2017
5	POEMS Syndrome (Syndrome, POEMS) 12/2022 - 10/2011
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2022 - 09/2015
4	Paraproteinemias (Monoclonal Gammopathy) 03/2024 - 10/2011
4	Residual Neoplasm 11/2023 - 01/2016
4	Lymphoma (Lymphomas) 01/2017 - 09/2015
3	Thrombocytopenia (Thrombopenia) 02/2024 - 01/2019
3	Bronchiolitis Obliterans Syndrome 01/2024 - 10/2020
3	Plasma Cell Leukemia 07/2021 - 12/2020
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2023 - 10/2008
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 11/2018
2	Fever (Fevers) 10/2021 - 01/2019
2	Diarrhea 10/2021 - 04/2013
2	Rare Diseases (Rare Disease) 01/2019 - 07/2012
2	Neutropenia 01/2019 - 10/2008
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 01/2016
2	Plasma Cell Neoplasms 12/2017 - 09/2013
2	Polyradiculoneuropathy (Polyradiculoneuritis) 09/2013 - 07/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2024
1	Monoclonal Gammopathy of Undetermined Significance 03/2024
1	Anemia 02/2024
1	Syndrome (Syndromes) 02/2024
1	Virus Diseases (Viral Diseases) 11/2023
1	Pain (Aches) 10/2023
1	Lymphopenia (Lymphocytopenia) 08/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 08/2023
1	Bites and Stings (Sting) 11/2022
1	Exanthema (Rash) 10/2021

Drug/Important Bio-Agent (IBA)

9	Amyloid (Amyloid Fibrils)IBA 10/2023 - 07/2013
8	Bortezomib (Velcade)FDA Link 11/2023 - 11/2015
8	Lenalidomide (CC 5013)FDA Link 11/2023 - 02/2017
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2012
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 02/2017
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 02/2017
6	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 01/2018
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024 - 01/2023
5	Chimeric Antigen ReceptorsIBA 02/2024 - 11/2022
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2015
4	B-Cell Maturation AntigenIBA 03/2024 - 01/2022
4	trans-crotonin (CTN)IBA 02/2024 - 01/2017
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 07/2013
3	Calcineurin InhibitorsIBA 01/2024 - 10/2016
3	ixazomibIBA 10/2022 - 01/2019
3	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 05/2018
3	Monoclonal AntibodiesIBA 01/2022 - 01/2020
3	CytokinesIBA 01/2021 - 09/2013
3	plerixafor FDA Link 12/2019 - 12/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 01/2018
2	daratumumabIBA 11/2023 - 01/2022
2	carfilzomibIBA 11/2023 - 01/2022
2	Proteasome InhibitorsIBA 01/2023 - 01/2020
2	pembrolizumabIBA 10/2021 - 01/2019
2	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2014
2	Busulfan (Busulfex)FDA Link 12/2020 - 01/2020
2	Doxycycline (Periostat)FDA LinkGeneric 06/2020 - 12/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2019 - 12/2014
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2019 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2013
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2018 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2017 - 04/2013
2	ProteomeIBA 06/2014 - 07/2013
2	Insulin (Novolin)FDA Link 06/2014 - 11/2012
1	phytobacteriomycin (PBM)IBA 03/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	COVID-19 VaccinesIBA 12/2023
1	Bispecific AntibodiesIBA 08/2023
1	mRNA VaccinesIBA 11/2022
1	pomalidomideIBA 12/2021
1	isatuximabIBA 12/2021
1	Budesonide (Pulmicort)FDA LinkGeneric 10/2021
1	APTIBA 03/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2021

Therapy/Procedure

56	Cell Transplantation 02/2024 - 09/2015
47	Therapeutics 03/2024 - 04/2013
18	Transplantation 01/2023 - 01/2013
10	Hematopoietic Stem Cell Transplantation 05/2023 - 11/2017
9	Drug Therapy (Chemotherapy) 01/2022 - 10/2008
8	Autologous Transplantation 01/2023 - 11/2015
7	Stem Cell Transplantation 11/2023 - 07/2012
5	Homologous Transplantation 01/2024 - 12/2015
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2024 - 01/2023
2	Withholding Treatment 11/2023 - 01/2022
2	Aftercare (After-Treatment) 11/2023 - 07/2017
2	Immunotherapy 01/2022 - 01/2021
2	Haploidentical Transplantation 01/2019 - 01/2018
2	Lasers (Laser) 06/2014 - 07/2013
1	Duration of Therapy 11/2023
1	Mammaplasty (Breast Reconstruction) 01/2023
1	Length of Stay 01/2023
1	Mastectomy (Mammectomy) 01/2023
1	Salvage Therapy 01/2022